0000950170-24-077850.txt : 20240626
0000950170-24-077850.hdr.sgml : 20240626
20240626160505
ACCESSION NUMBER: 0000950170-24-077850
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221231
FILED AS OF DATE: 20240626
DATE AS OF CHANGE: 20240626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shuman Harry
CENTRAL INDEX KEY: 0001791115
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 241073429
MAIL ADDRESS:
STREET 1: C/O MERUS N.V.
STREET 2: VALELAAN 62
CITY: UTRECHT
STATE: P7
ZIP: 3584 CM
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
5
1
ownership.xml
5
X0508
5
2022-12-31
0
1
0001651311
Merus N.V.
MRUS
0001791115
Shuman Harry
C/O MERUS N.V.
UPPSALALAAN 17
UTRECHT
P7
3584 CT
NETHERLANDS
false
true
false
false
VP Controller, PAO
false
Share Option (right to buy)
2022-02-14
4
A
false
1000
0
A
2032-02-14
Common Stock
1000
1000
D
Represents the exercise price of the options originally granted on February 14, 2022.
Options vested over a one-year period from January 3, 2022. 50% vested on July 3, 2022 and the remaining vested in 6 equal monthly installments thereafter.
This transaction reflects share options granted as part of a Company incentive program that were inadvertantly omitted in 2022.
/s/ Peter Silverman as attorney-in-fact
2024-06-13